Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Ferris, Robert L; Cohen, Ezra; Gash, Kelly; Whiting, Sam; Manjarrez, Kristi; Dietsch, Greg; Hershberg, Robert; Bryan, James Kyle

doi:10.1186/2051-1426-2-S3-P69

Article metrics
Last updated: Fri, 26 Apr 2024 9:18:46 Z

Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Access & Citations

669

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.